Você procurou por: blödningsincident (Sueco - Inglês)

andelen patienter som fick minst en blödningsincident i de två behandlingsgrupperna var 24,9 % respektive 17,7 %.
the percentage of patients experiencing at least one bleeding event in the two treatment groups was 24.9% and 17.7%, respectively.

i address-studien var andelen behandlade patienter som fick en allvarlig blödningsincident vid de olika blödningsställena likartad den som observerades i prowess-studien.
in address, the percent of treated patients experiencing a serious bleeding event by site of haemorrhage was similar to that observed in prowess.

andelen patienter som fick minst en blödningsincident i de båda behandlingsgrupperna var 10,9 % respektive 6,4 % (p < 0,001).
the percentage of patients experiencing at least one bleeding event in the two treatment groups was 10.9% and 6.4%, respectively (p<0.001).

i den placebokontrollerade address-studien var incidensen allvarlig blödningsincident under studieperioden på 28 dagar 51 (3,9 %) för patienter behandlade med drotrecogin alfa (aktiverat) och 28 (2,2 %) för placebobehandlade patienter (p = 0,01).
in the placebo-controlled address study, the incidence of serious bleeding events during the 28-day study period was 51 (3.9%) and 28 (2.2%) in drotrecogin alfa (activated)-treated and placebo-treated patients, respectively (p=0.01).